RecruitingPHASE2, PHASE3NCT04302870
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Edinburgh
- Principal Investigator
- Professor ChandranUniversity of Edinburgh
- Intervention
- Memantine Hydrochloride Oral Solution(drug)
- Enrollment
- 1150 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2030
Study locations (22)
- Southern Health and Social Care Trust, Craigavon Area Hospital, Portadown, County Armagh, United Kingdom
- Aberdeen Royal Infirmary, Aberdeen, United Kingdom
- University Hospitals of Birmingham NHS Foundation Trust, Birmingham, United Kingdom
- University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom
- West Suffolk NHS Foundation Trust, Bury St Edmunds, United Kingdom
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
- Cardiff and Vale University Local Health Board, Cardiff, United Kingdom
- Clinical Research Centre , Ninewells Hospital, Dundee, United Kingdom
- Anne Rowling Regenerative Neurology Clinic, Edinburgh, United Kingdom
- Royal Devon and Exeter Hospital, Exeter, United Kingdom
- Queen Elizabeth University Hospital Clinical Research Facility, Glasgow, United Kingdom
- NHS Highland Clinical Research Facility, Raigmore Hospital, Inverness, United Kingdom
- East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom
- Royal London Hospital, London, United Kingdom
- St George's University Hospitals NHS Foundation Trust, London, United Kingdom
- +7 more locations on ClinicalTrials.gov
Collaborators
University College, London · University of Warwick · NHS Lothian
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04302870 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia